Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective Study

Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective Study

IntroductionLess than one-third of bladder cancers are non-pure urothelial carcinoma [with variant histological (VH) or non-urothelial carcinoma (non-UC)] for which no treatment guidelines are available. We aim to evaluate the efficacy of systemic treatments in VH or non-UC bladder cancers.Materials...

Full description

Bibliographic Details
Main Authors: Nicolas Epaillard, Pauline Parent, Yohann Loriot, Pernelle Lavaud, E-B. Vera-Cea, Nieves Martinez-Chanza, Alejo Rodriguez-Vida, Clement Dumont, Rebeca Lozano, Casilda Llácer, Raffaele Ratta, Stephane Oudard, Constance Thibault, Edouard Auclin
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
urinary bladder neoplasms
variant histology
drug therapy
immunotherapy
mortality
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.671969/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.671969/full

Similar Items